Nasdaq - Delayed Quote
USD
BNY Mellon Sm/Md Cp Gr Z (DBMZX)
21.21
-0.61
(-2.80%)
At close: October 30 at 8:01:10 PM EDT
Fund Summary
To pursue its goal, the fund normally invests at least 80% of its net assets, plus any borrowings for investment purposes, in equity securities of small-cap and mid-cap U.S. companies. The adviser considers small-cap and mid-cap companies to be those companies with total market capitalizations that are equal to or less than the total market capitalization of the largest company included in the Russell 2500TM Growth Index.
BNY Mellon Sm/Md Cp Gr Z
New York, NY 10166
200 Park Avenue
Fund Overview
| Category | Mid-Cap Growth |
| Fund Family | BNY Mellon |
| Net Assets | 728.02M |
| YTD Return | 3.41% |
| Yield | 0.00% |
| Morningstar Rating | |
| Inception Date | Jan 19, 2018 |
Fund Operations
| Last Dividend | -- |
| Last Cap Gain | 40.00 |
|---|---|
| Holdings Turnover | 131.25% |
| Average for Category | -- |
Fees & Expenses
| Expense | DBMZX | Category Average |
|---|---|---|
|
Annual Report Expense Ratio (net)
|
0.88% | 1.09% |
|
Prospectus Net Expense Ratio
|
0.88% | -- |
|
Prospectus Gross Expense Ratio
|
0.88% | -- |
|
Max 12b1 Fee
|
-- | -- |
|
Max Front End Sales Load
|
-- | 5.36% |
|
Max Deferred Sales Load
|
-- | 1.27% |
|
3 Yr Expense Projection
|
0 | -- |
|
5 Yr Expense Projection
|
0 | -- |
|
10 Yr Expense Projection
|
0 | -- |
Management Information
Morningstar Style Box
